PD Dr. med. univ.
Andreas Lutterotti
PD Andreas Lutterotti completed his training as a specialist in neurology at the Department of Neurology of the Medical University of Innsbruck. During his training, he went for a fellowship as a researcher at the Institute of Neuroimmunology and Clinical MS Research at the University of Hamburg. After working as a senior physician, he received an assistant professorship at the Medical University of Innsbruck and was appointed to an assistant professorship at the University of Zurich in 2014. During the time, he headed the neurological day clinic, the cerebrospinal fluid laboratory, and later the neuroimmunological outpatient clinic at the Neurology Clinic of the University Hospital Zurich. His clinical focus is on neuroimmunological disorders and multiple sclerosis. His research focus on experimental therapies led to the spin-out of the company Cellerys, which is developing a new therapy for MS and which he oversees in a leading role.
Since 2021, he has been a senior physician at the Neurozentrum Bellevue and the Clinic for Neurology Hirslanden. He is a member of the Swiss and European neurological societies.
Seit September 2021
Leitender Arzt, Neuroimmunologische Ambulanz, Neurozentrum Bellevue und Klinik für Neurologie, Hirslanden, Zürich
Seit Mai 2021
Medizinischer Leiter, Cellerys AG, Zürich
August 2014– April 2021
Leitender Oberarzt, Leiter des MS-Ambulatoriums, Leiter der Neurologischen Tagesklinik, Klinik für Neurologie, USZ.
August 2014– Juli 2020
Assistenzprofessor “Experimentelle Therapieforschung bei Multipler Sklerose und anderen neurologischen Erkrankungen”, UZH;
September 2013
Ernennung zum Assistenzprofessor, Klinische Abteilung für Neurologie, Medizinische Universität Innsbruck
April 2014
Leitender Oberarzt, Klinische Abteilung für Neurologie, Medizinische Universität Innsbruck
Januar 2012
Zertifizierung in Neurologie
2003 – 2011
Ausbildung in Klinischer Neurologie, Medizinische Universität Innsbruck
2001 – 2003
Postdoktorand in der Neuroimmunologie Gruppe (Prof. Thomas Berger und Prof. Markus Reindl), Klinische Abteilung für Neurologie, Medizinische Universität Innsbruck
Oktober 2015
Habilitation, Medizinische Universität Innsbruck
Oktober 2001
Abschluss zum MD
1993 – 2001
Studium der Medizin an der Medizinischen Universität Innsbruck, Österreich